The DOI matches its Crossref record; 115 of the 115 references it cites were found in a registry or an index.
Genetic and epigenetic biomarkers for diagnosis, prognosis and treatment of colorectal cancer
Open accessAbstract
Colorectal cancer (CRC) is one of the most common cancer worldwide and results from the accumulation of mutations and epimutations in colonic mucosa cells ultimately leading to cell proliferation and metastasis. Unfortunately, CRC prognosis is still poor and the search of novel diagnostic and prognostic biomarkers is highly desired to prevent CRC-related deaths. The present article aims to summarize the most recent findings concerning the use of either genetic or epigenetic (mainly related to DNA methylation) biomarkers for CRC diagnosis, prognosis, and response to treatment. Recent large-scale DNA methylation studies suggest that CRC can be divided into several subtypes according to the frequency of DNA methylation and those of mutations in key CRC genes, and that this is reflected by different prognostic outcomes. Increasing evidence suggests that the analysis of DNA methylation in blood or fecal specimens could represent a valuable non-invasive diagnostic tool for CRC. Moreover, a broad spectrum of studies indicates that the inter-individual response to chemotherapeutic treatments depends on both epigenetic modifications and genetic mutations occurring in colorectal cancer cells, thereby opening the way for a personalized medicine. Overall, combining genetic and epigenetic data might represent the most promising tool for a proper diagnostic, prognostic and therapeutic approach.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Two new Later Stone Age sites from the Final Pleistocene in the Falémé Valley, eastern Senegal
Ndiaye, M., Lespez, L., Tribolo, C., Rassé, M., Hadjas, I., Davidoux, S., Huysecom, É., & Douze, K. (2024) · Monash University Research Portal (Monash University) · doi:10.3929/ethz-b-000667478 · Cited by 23,868
A genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132
K-ras Mutations and Benefit from Cetuximab in Advanced Colorectal Cancer
Karapetis, C. S., Khambata-Ford, S., Jonker, D. J., O'Callaghan, C. J., Tu, D., Tebbutt, N. C., Simes, R. J., Chalchal, H., Shapiro, J. D., Robitaille, S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0804385 · Cited by 3,622
High Frequency of Mutations of the PIK3CA Gene in Human Cancers
Samuels, Y., Wang, Z., Bardelli, A., Silliman, N., Ptak, J., Szabo, S., Yan, H., Gazdar, A., Powell, S. M., Riggins, G. J., et al. (2004) · Science · doi:10.1126/science.1096502 · Cited by 3,437
Cancer epigenetics: from mechanism to therapy
Dawson, M. A., & Kouzarides, T. (2012) · Cell · doi:10.1016/j.cell.2012.06.013 · Cited by 3,203
CpG island methylator phenotype in colorectal cancer
Toyota, M., Ahuja, N., Ohe-Toyota, M., Herman, J. G., Baylin, S. B., & Issa, J.-P. J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.15.8681 · Cited by 2,523
Hypomethylation distinguishes genes of some human cancers from their normal counterparts
Feinberg, A. P., & Vogelstein, B. (1983) · Nature · doi:10.1038/301089a0 · Cited by 2,437
Drug delivery with carbon nanotubes for in vivo cancer treatment
Liu, Z., Chen, K., Davis, C. R., Sherlock, S. P., Cao, Q., Chen, X. S., & Dai, H. (2008) · PubMed · doi:10.48550/arxiv.0808.2070 · Cited by 2,286
De Roock, W., Claes, B., Bernasconi, D., De Schutter, J., Biesmans, B., Fountzilas, G., Kalogeras, K. T., Kotoula, V., Papamichael, D., Laurent-Puig, P., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70130-3 · Cited by 2,144
Van Cutsem, E., Köhne, C.-H., Láng, I., Folprecht, G., Nowacki, M. P., Cascinu, S., Shchepotin, I., Maurel, J., Cunningham, D., Tejpar, S., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.5091 · Cited by 1,882
Systematic Review of Microsatellite Instability and Colorectal Cancer Prognosis
Popat, S., Hubner, R., & Houlston, R. S. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.086 · Cited by 1,830
Sargent, D. J., Marsoni, S., Monges, G., Thibodeau, S. N., Labianca, R., Hamilton, S. R., French, A. J., Kabat, B., Foster, N. R., Torri, V., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.1825 · Cited by 1,623
Wild-Type BRAF Is Required for Response to Panitumumab or Cetuximab in Metastatic Colorectal Cancer
Di Nicolantonio, F., Martini, M., Molinari, F., Sartore-Bianchi, A., Arena, S., Saletti, P., De Dosso, S., Mazzucchelli, L., Frattini, M., Siena, S., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.0786 · Cited by 1,591
Cancer Research Communications
(2021) · doi:10.1158/1078-0432 · Cited by 1,532
Cancer Genetics and Epigenetics: Two Sides of the Same Coin?
You, J. S., & Jones, P. A. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.06.008 · Cited by 1,167
Peeters, M., Price, T. J., Cervantes, A., Sobrero, A. F., Ducreux, M., Hotko, Y., André, T., Chan, E., Lordick, F., Punt, C. J. A., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.6055 · Cited by 1,005
Genomic and Epigenetic Instability in Colorectal Cancer Pathogenesis
Grady, W. M., & Carethers, J. M. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.07.076 · Cited by 960
The Epidermal Growth Factor Receptor Pathway: A Model for Targeted Therapy
Scaltriti, M., & Baselga, J. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1554 · Cited by 913
Cluster-Randomized Trial to Increase Hepatitis B Testing among Koreans in Los Angeles
Bastani, R., Glenn, B. A., & Maxwell, A. E. (2015) · eCite Digital Repository (University of Tasmania) · doi:10.1158/1055-9965 · Cited by 901
Aspirin Use, Tumor PIK3CA Mutation, and Colorectal-Cancer Survival
Liao, X., Lochhead, P., Nishihara, R., Morikawa, T., Kuchiba, A., Yamauchi, M., Imamura, Y., Qian, Z. R., Baba, Y., Shima, K., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1207756 · Cited by 843
De Roock, W., Piessevaux, H., De Schutter, J., Janssens, M., De Hertogh, G., Personeni, N., Biesmans, B., Van Laethem, J.-L., Peeters, M., Humblet, Y., et al. (2008) · Annals of Oncology · doi:10.1093/annonc/mdm496 · Cited by 827
Tran, B., Kopetz, S., Tie, J., Gibbs, P., Jiang, Z., Lieu, C. H., Agarwal, A., Maru, D. M., Sieber, O., & Desai, J. (2011) · Cancer · doi:10.1002/cncr.26086 · Cited by 797
Bokemeyer, C., Bondarenko, I., Hartmann, J. T., de Braud, F., Schuch, G., Zubel, A., Celik, I., Schlichting, M., & Koralewski, P. (2011) · Annals of Oncology · doi:10.1093/annonc/mdq632 · Cited by 775
De Roock, W., Jonker, D. J., Di Nicolantonio, F., Sartore-Bianchi, A., Tu, D., Siena, S., Lamba, S., Arena, S., Frattini, M., Piessevaux, H., et al. (2010) · JAMA · doi:10.1001/jama.2010.1535 · Cited by 748
DNA methylation profiling in the clinic: applications and challenges
Heyn, H., & Esteller, M. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3270 · Cited by 746
Epigenetics and colorectal cancer
Lao, V. V., & Grady, W. M. (2011) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2011.173 · Cited by 736
Genome-scale analysis of aberrant DNA methylation in colorectal cancer
Hinoue, T., Weisenberger, D. J., Lange, C. P. E., Shen, H., Byun, H.-M., Van Den Berg, D., Malik, S., Pan, F., Noushmehr, H., van Dijk, C. M., et al. (2012) · Genome Research · doi:10.1101/gr.117523.110 · Cited by 601
Integrated genetic and epigenetic analysis identifies three different subclasses of colon cancer
Shen, L., Toyota, M., Kondo, Y., Lin, E., Zhang, L., Guo, Y., Hernandez, N. S., Chen, X., Ahmed, S., Konishi, K., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704652104 · Cited by 559
Sinicrope, F. A., Foster, N. R., Thibodeau, S. N., Marsoni, S., Monges, G., Labianca, R., Yothers, G., Allegra, C., Moore, M. J., Gallinger, S., et al. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr153 · Cited by 543
Circulating Methylated SEPT9 DNA in Plasma Is a Biomarker for Colorectal Cancer
deVos, T., Tetzner, R., Model, F., Weiss, G., Schuster, M., Distler, J., Steiger, K. V., Grützmann, R., Pilarsky, C., Habermann, J. K., et al. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2008.115808 · Cited by 522
Hypomethylation of ras oncogenes in primary human cancers
Feinberg, A. P., & Vogelstein, B. (1983) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(83)80115-6 · Cited by 514
Zhao, L., & Vogt, P. K. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712169105 · Cited by 437
Russo, A., Bazan, V., Iacopetta, B., Kerr, D., Soussi, T., & Gebbia, N. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.00.471 · Cited by 416
Sensitive Detection of Colorectal Cancer in Peripheral Blood by Septin 9 DNA Methylation Assay
Grützmann, R., Molnar, B., Pilarsky, C., Habermann, J. K., Schlag, P. M., Saeger, H. D., Miehlke, S., Stolz, T., Model, F., Roblick, U. J., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003759 · Cited by 394
Microsatellite instability and colorectal cancer prognosis
Benatti, P., Gafà, R., Barana, D., Marino, M., Scarselli, A., Pedroni, M., Maestri, I., Guerzoni, L., Roncucci, L., Menigatti, M., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1030 · Cited by 379
Association between chromosomal instability and prognosis in colorectal cancer: a meta-analysis
Walther, A., Houlston, R., & Tomlinson, I. (2008) · Gut · doi:10.1136/gut.2007.135004 · Cited by 368
Tejpar, S., Celik, I., Schlichting, M., Sartorius, U., Bokemeyer, C., & Van Cutsem, E. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.42.2592 · Cited by 353
SMAD2,SMAD3 and SMAD4 Mutations in Colorectal Cancer
Fleming, N. I., Jorissen, R. N., Mouradov, D., Christie, M., Sakthianandeswaren, A., Palmieri, M., Day, F., Li, S., Tsui, C., Lipton, L., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2706 · Cited by 324
Goel, A., Nagasaka, T., Arnold, C. N., Inoue, T., Hamilton, C., Niedzwiecki, D., Compton, C., Mayer, R. J., Goldberg, R., Bertagnolli, M. M., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2006.09.018 · Cited by 300
Hur, K., Cejas, P., Feliu, J., Moreno-Rubio, J., Burgos, E., Boland, C. R., & Goel, A. (2014) · Gut · doi:10.1136/gutjnl-2012-304219 · Cited by 299
Integrated Analysis of Molecular and Clinical Prognostic Factors in Stage II/III Colon Cancer
Roth, A. D., Delorenzi, M., Tejpar, S., Yan, P., Klingbiel, D., Fiocca, R., d'Ario, G., Cisar, L., Labianca, R., Cunningham, D., et al. (2012) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djs427 · Cited by 284
Prognostic and predictive factors in colorectal cancer
Zlobec, I., & Lugli, A. (2008) · Postgraduate Medical Journal · doi:10.1136/jcp.2007.054858 · Cited by 280
Genetics, Cytogenetics, and Epigenetics of Colorectal Cancer
Migliore, L., Migheli, F., Spisni, R., & Coppedè, F. (2011) · BioMed Research International · doi:10.1155/2011/792362 · Cited by 278
Self-citationEpigenetics of Colorectal Cancer
Goel, A., & Boland, C. R. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.09.032 · Cited by 273
Prognostic Role of PIK3CA Mutation in Colorectal Cancer: Cohort Study and Literature Review
Liao, X., Morikawa, T., Lochhead, P., Imamura, Y., Kuchiba, A., Yamauchi, M., Nosho, K., Qian, Z. R., Nishihara, R., Meyerhardt, J. A., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2410 · Cited by 258
A High Degree of LINE-1 Hypomethylation Is a Unique Feature of Early-Onset Colorectal Cancer
Antelo, M., Balaguer, F., Shia, J., Shen, Y., Hur, K., Moreira, L., Cuatrecasas, M., Bujanda, L., Giraldez, M. D., Takahashi, M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045357 · Cited by 249
Raf kinase as a target for anticancer therapeutics
Sridhar, S. S., Hedley, D., & Siu, L. L. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-04-0297 · Cited by 245
Peeters, M., Douillard, J.-Y., Van Cutsem, E., Siena, S., Zhang, K., Williams, R., & Wiezorek, J. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.45.1492 · Cited by 232
Bazan, V., Migliavacca, M., Zanna, I., Tubiolo, C., Grassi, N., Latteri, M. A., La Farina, M., Albanese, I., Dardanoni, G., Salerno, S., et al. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf226 · Cited by 225
Antimetastatic Role of Smad4 Signaling in Colorectal Cancer
Zhang, B., Halder, S. K., Kashikar, N. D., Cho, Y., Datta, A., Gorden, D. L., & Datta, P. K. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.11.004 · Cited by 221
Tol, J., Dijkstra, J. R., Klomp, M., Teerenstra, S., Dommerholt, M., Vink-Börger, M. E., van Cleef, P. H., van Krieken, J. H., Punt, C. J. A., & Nagtegaal, I. D. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.03.036 · Cited by 210
Tänzer, M., Balluff, B., Distler, J., Hale, K., Leodolter, A., Röcken, C., Molnar, B., Schmid, R., Lofton-Day, C., Schuster, T., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009061 · Cited by 191
TFAP2E–DKK4 and Chemoresistance in Colorectal Cancer
Ebert, M. P. A., Tänzer, M., Balluff, B., Burgermeister, E., Kretzschmar, A. K., Hughes, D. J., Tetzner, R., Lofton-Day, C., Rosenberg, R., Reinacher-Schick, A. C., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1009473 · Cited by 189
Mao, C., Yang, Z. Y., Hu, X. F., Chen, Q., & Tang, J. L. (2012) · Annals of Oncology · doi:10.1093/annonc/mdr464 · Cited by 188
Oh, T., Kim, N., Moon, Y., Kim, M. S., Hoehn, B. D., Park, C. H., Kim, T. S., Kim, N. K., Chung, H. C., & An, S. (2013) · The Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2013.03.004 · Cited by 176
Aspirin Use and Risk of Colorectal Cancer According to BRAF Mutation Status
Nishihara, R., Lochhead, P., Kuchiba, A., Jung, S., Yamauchi, M., Liao, X., Imamura, Y., Qian, Z. R., Morikawa, T., Wang, M., et al. (2013) · JAMA · doi:10.1001/jama.2013.6599 · Cited by 166
A Simplified, Noninvasive Stool DNA Test for Colorectal Cancer Detection
Itzkowitz, S., Brand, R., Jandorf, L., Durkee, K., Millholland, J., Rabeneck, L., Schroy, P. C., Sontag, S., Johnson, D., Markowitz, S., et al. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.02088.x · Cited by 161
Rosty, C., Young, J. P., Walsh, M. D., Clendenning, M., Sanderson, K., Walters, R., Parry, S., Jenkins, M. A., Win, A. K., Southey, M. C., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065479 · Cited by 153
Crea, F., Nobili, S., Paolicchi, E., Perrone, G., Napoli, C., Landini, I., Danesi, R., & Mini, E. (2011) · Drug Resistance Updates · doi:10.1016/j.drup.2011.08.001 · Cited by 153
Genomic and Epigenomic Integration Identifies a Prognostic Signature in Colon Cancer
Yi, J. M., Dhir, M., Neste, L. V., Downing, S. R., Jeschke, J., Glöckner, S. C., Calmon, M. F., Hooker, C. M., Funes, J. M., Boshoff, C., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2509 · Cited by 146
Are KRAS/BRAF Mutations Potent Prognostic and/or Predictive Biomarkers in Colorectal Cancers?
Yokota, T. (2012) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152012799014968 · Cited by 138
Mutations in Both KRAS and BRAF May Contribute to the Methylator Phenotype in Colon Cancer
Nagasaka, T., Koi, M., Kloor, M., Gebert, J. F., Vilkin, A., Nishida, N., Shin, S. K., Sasamoto, H., Tanaka, N., Matsubara, N., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.02.094 · Cited by 130
The prognostic value of CDKN2A hypermethylation in colorectal cancer: a meta-analysis
Xing, X., Cai, W., Shi, H., Wang, Y., Li, M., Jiao, J., & Chen, M. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.251 · Cited by 129
Amatu, A., Bianchi, A. S., Moutinho, C., Belotti, A., Bencardino, K. B., Chirico, G. G., Cassingena, A., Rusconi, F., Esposito, A., Nichelatti, M., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3518 · Cited by 125
Genome-Scale Discovery of DNA-Methylation Biomarkers for Blood-Based Detection of Colorectal Cancer
Lange, C. P. E., Campan, M., Hinoue, T., Schmitz, R. F., Jong, A. E. V. D. M., Slingerland, H., Kok, P. J. M. J., van Dijk, C. M., Weisenberger, D. J., Shen, H., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050266 · Cited by 120
Epigenetic silencing of miR-126 contributes to tumor invasion and angiogenesis in colorectal cancer
Zhang, Y., Wang, X., Xu, B., Wang, B., Wang, Z., Liang, Y., Zhou, J., Hu, J., & Jiang, B. (2013) · Oncology Reports · doi:10.3892/or.2013.2633 · Cited by 116
Pentheroudakis, G., Kotoula, V., De Roock, W., Kouvatseas, G., Papakostas, P., Makatsoris, T., Papamichael, D., Xanthakis, I., Sgouros, J., Televantou, D., et al. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-49 · Cited by 111
Epigenetic biomarkers of colorectal cancer: Focus on DNA methylation
Coppedè, F. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.12.030 · Cited by 111
Self-citationCheetham, S., Tang, M., Mesak, F., Kennecke, H. F., Owen, D., & Tai, I. T. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604377 · Cited by 111
Distinct Genetic Alterations in Colorectal Cancer
Ashktorab, H., Schäffer, A. A., Daremipouran, M., Smoot, D. T., Lee, E. B., & Brim, H. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008879 · Cited by 111
Sood, A., McClain, D., Maitra, R., Basu-Mallick, A., Seetharam, R. N., Kaubisch, A., Rajdev, L. N., Mariadason, J. M., Tanaka, K. E., & Goel, S. (2012) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2011.12.001 · Cited by 111
SMAD4 Levels and Response to 5-Fluorouracil in Colorectal Cancer
Alhopuro, P., Alazzouzi, H., Sammalkorpi, H., Dávalos, V., Salovaara, R., Hemminki, A., Järvinen, H., Mecklin, J., Schwartz, S., Aaltonen, L. A., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0244 · Cited by 111
Tang, D., Liu, J., Wang, D., Yu, H., Li, Y., & Zhang, J. (2011) · Clinical and investigative medicine · doi:10.25011/cim.v34i1.15105 · Cited by 92
oden-Gangloff, A., Fiore, F. D., Bibeau, F., Lamy, A., Bougeard, G., Charbonnier, F., Blanchard, F., Tougeron, D., Ychou, M., Boissière‐Michot, F., et al. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605008 · Cited by 92
The molecular biology of colorectal carcinoma and its implications: A review
Harrison, S., & Benziger, H. (2011) · The Surgeon · doi:10.1016/j.surge.2011.01.011 · Cited by 89
Baba, Y., Nosho, K., Shima, K., Huttenhower, C., Tanaka, N., Hazra, A., Giovannucci, E. L., Fuchs, C. S., & Ogino, S. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.07.050 · Cited by 89
APC Polymorphisms and the Risk of Colorectal Neoplasia: A HuGE Review and Meta-Analysis
Liang, J., Lin, C., Hu, F., Wang, F., Zhu, L., Yao, X., Wang, Y., & Zhao, Y. (2013) · American Journal of Epidemiology · doi:10.1093/aje/kws382 · Cited by 87
Takahashi, Y., Iwaya, T., Sawada, G., Kurashige, J., Matsumura, T., Uchi, R., Ueo, H., Takano, Y., Eguchi, H., Sudo, T., et al. (2013) · Annals of Surgical Oncology · doi:10.1245/s10434-013-3264-3 · Cited by 84
Bazan, V., Agnese, V., Corsale, S., Calò, V., Valerio, M. R., Latteri, M. A., Vieni, S., Grassi, N., Cicero, G., Dardanoni, G., et al. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi908 · Cited by 84
Sastre, J., Aranda, E., Grávalos, C., Massutí, B., Varella‐Garcia, M., Rivera, F., Soler, G., Carrato, A., Manzano, J. L., Díaz‐Rubio, E., et al. (2009) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2009.11.005 · Cited by 70
Epigenetic Silencing of HOPX Promotes Cancer Progression in Colorectal Cancer
Katoh, H., Yamashita, K., Waraya, M., Margalit, O., Ooki, A., Tamaki, H., Sakagami, H., Kokubo, K., Sidransky, D., & Watanabe, M. (2012) · Neoplasia · doi:10.1593/neo.12330 · Cited by 69
Clinical significance of microsatellite instability in colorectal cancer
Kloor, M., Staffa, L., Ahadova, A., & Doeberitz, M. V. K. (2013) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-013-1112-3 · Cited by 69
Nilsson, T., Löf-Öhlin, Z. M., & Sun, X. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1682 · Cited by 68
Epigenetic Drivers of Genetic Alterations
Toyota, M., & Suzuki, H. (2010) · Advances in genetics · doi:10.1016/b978-0-12-380866-0.60011-3 · Cited by 66
Chen, T. ‐., Chang, S., Huang, C., Wang, K. ‐., Yeh, K., Liu, C., Lee, H., Lin, C., & Cheng, Y. ‐. (2013) · Colorectal Disease · doi:10.1111/codi.12318 · Cited by 64
Alterations in the EGFR pathway coincide in colorectal cancer and impact on prognosis
Neumann, J. H. L., Wehweck, L., Maatz, S., Engel, J., Kirchner, T., & Jung, A. (2013) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-013-1450-0 · Cited by 59
Detection of hypermethylated fibrillin-1 in the stool samples of colorectal cancer patients
Guo, Q., Song, Y., Zhang, H., Wu, X., Xia, P., & Dang, C. (2013) · Medical Oncology · doi:10.1007/s12032-013-0695-4 · Cited by 58
Petrelli, F., Coinu, A., Cabiddu, M., Ghilardi, M., & Barni, S. (2013) · Medical Oncology · doi:10.1007/s12032-013-0650-4 · Cited by 56
Xu, Q., Xu, A. T., Zhu, M., Tong, J. L., Xi Tao, X. U., & Ran, Z. H. (2013) · Journal of Digestive Diseases · doi:10.1111/1751-2980.12063 · Cited by 55
Danese, E., Minicozzi, A. M., Benati, M., Montagnana, M., Paviati, E., Salvagno, G. L., Gusella, M., Pasini, F., Guidi, G. C., & Lippi, G. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.351 · Cited by 55
Rhee, Y.-Y., Kim, M. J., Bae, J. M., Koh, J. M., Cho, N., Juhnn, Y., Kim, D., & Kang, G. H. (2012) · Annals of Surgical Oncology · doi:10.1245/s10434-012-2410-7 · Cited by 53
Chemotherapy of MMR-deficient colorectal cancer
Devaud, N., & Gallinger, S. (2013) · Familial Cancer · doi:10.1007/s10689-013-9633-z · Cited by 53
Genome-Wide Screening of Genes Regulated by DNA Methylation in Colon Cancer Development
Spisák, S., Kalmár, A., Galamb, O., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046215 · Cited by 52
Summers, T. A., Langan, R. C., Nissan, A., Brücher, B. L. D. M., Bilchik, A. J., Protić, M., Däumer, M., Avital, I., & Stojadinovic, A. (2013) · Journal of Cancer · doi:10.7150/jca.5839 · Cited by 50
Chen, J., Ye, Y., Sun, H., & Shi, G. (2012) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-012-2005-9 · Cited by 48
Prognostic and predictive factors in colorectal cancer.
Bolocan, A., Ion, D., Ciocan, D. N., & Paduraru, D. N. (2012) · PubMed · Cited by 48
Cushman‐Vokoun, A. M., Stover, D. G., Zhao, Z., Koehler, E., Berlin, J. D., & Vnencak‐Jones, C. L. (2013) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2013.04.005 · Cited by 45
Yang, H., Xia, B., Jiang, B., Wang, G., Yang, Y., Chen, H. H., Li, B., Xu, A., Huang, Y.-B., & Wang, X. (2013) · Canadian Journal of Gastroenterology · doi:10.1155/2013/258030 · Cited by 44
Muñoz‐Bellvís, L., Fontanillo, C., González‐González, M., García, E., Iglesias, M. J. I., Esteban, C., Gutiérrez, M. L., Abad, M. M., Bengoechea, Ó., Rivas, J. D. L., et al. (2012) · Modern Pathology · doi:10.1038/modpathol.2011.195 · Cited by 43
The role of tumor markers and biomarkers in colorectal cancer
Lech, G., Słotwiński, R., & Krasnodebski, I. W. (2013) · Neoplasma · doi:10.4149/neo_2014_003 · Cited by 41
Epigenetic Alteration of DNA in Mucosal Wash Fluid Predicts Invasiveness of Colorectal Tumors
Kamimae, S., Yamamoto, E., Yamano, H., Nojima, M., Suzuki, H., Ashida, M., Hatahira, T., Satô, A., Kimura, T., Yoshikawa, K., et al. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0214 · Cited by 41
Specific genomic aberrations in primary colorectal cancer are associated with liver metastases
Bruin, S. C., Klijn, C. N., Liefers, G., Braaf, L. M., Joosse, S. A., van Beers, E. H., Verwaal, V. J., Morreau, H. M., Wessels, L. F. A., van Velthuysen, M. F., et al. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-662 · Cited by 41
Soeda, H., Shimodaira, H., Watanabe, M., Suzuki, T., Gamoh, M., Mori, T., Komine, K., Iwama, N., Kato, S., & Ishioka, C. (2012) · International Journal of Clinical Oncology · doi:10.1007/s10147-012-0422-8 · Cited by 38
Ting, W.-C., Chen, L.-M., Pao, J.-B., Yang, Y.-P., You, B., Chang, T.-Y., Lan, Y., Lee, H., & Bao, B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056196 · Cited by 38
Losso, G. M., Moraes, R. D. S., Gentili, A. C., & Messias-Reason, I. (2012) · ABCD Arquivos Brasileiros de Cirurgia Digestiva (São Paulo) · doi:10.1590/s0102-67202012000400006 · Cited by 36
Wangefjord, S., Sundström, M., Zendehrokh, N., Lindquist, K. E., Nodin, B., Jirström, K., & Eberhard, J. (2013) · Biology of Sex Differences · doi:10.1186/2042-6410-4-17 · Cited by 36
Tzeng, S., Tsai, M., Chen, C., Lee, J.-X., Jao, T., Yu, S., Yen, S., & Yang, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067040 · Cited by 35
Shull, A. Y., Clendenning, M., Ghoshal-Gupta, S., Farrell, C. L., Vangapandu, H. V., Dudas, L., Wilkerson, B. J., & Buckhaults, P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058731 · Cited by 34
Clinical Applications of DNA Methylation Biomarkers in Colorectal Cancer
Lange, C. P. E., & Laird, P. W. (2013) · Epigenomics · doi:10.2217/epi.13.4 · Cited by 32
Luo, Y., Chen, D.-K., Song, S., Wang, L., & WANG, J.-P. (2011) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2011.02800.x · Cited by 31
Tural, D. G., Batur, Ş., Erdamar, S., Akar, E., Kepil, N., Mandel, N. M., & Serdengeçti, S. (2013) · Tumor Biology · doi:10.1007/s13277-013-1138-8 · Cited by 28
Jensen, L. H., Rasmussen, A. A., Byriel, L., Kuramochi, H., Crüger, D. G., Lindebjerg, J., Danenberg, P. V., Jakobsen, A. K. M., & Danenberg, K. D. (2013) · Cellular Oncology · doi:10.1007/s13402-013-0148-2 · Cited by 25
Sawada, T., Yamamoto, E., Suzuki, H., Nojima, M., Maruyama, R., Shioi, Y., Akasaka, R., Kamimae, S., Harada, T., Ashida, M., et al. (2012) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22013 · Cited by 23
González‐González, M., Muñoz‐Bellvís, L., Mackintosh, C., Fontanillo, C., Gutiérrez, M. L., Abad, M. M., Bengoechea, Ó., Teodósio, C., Fonseca, E., Fuentes, M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042683 · Cited by 19
Prognostic Significance of 18q Loss of Heterzygosity in Microsatellite-Stable Colorectal Cancer
Watanabe, T., Kobunai, T., Yamamoto, Y., Konishi, T., Yano, H., Iinuma, H., Hayama, T., Nozawa, K., Ishihara, S., & Matsuda, K. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.0256 · Cited by 12
Cited by
Sawicki, T., Ruszkowska, M., Danielewicz, A., Niedźwiedzka, E., Arłukowicz, T., & Przybyłowicz, K. E. (2021) · Cancers · doi:10.3390/cancers13092025 · Cited by 921
MicroRNA-494 promotes cancer progression and targets adenomatous polyposis coli in colorectal cancer
Zhang, Y., Guo, L., Li, Y., Feng, G.-H., Teng, F., Li, W., & Zhou, Q. (2018) · Molecular Cancer · doi:10.1186/s12943-017-0753-1 · Cited by 326
The molecular characteristics of colorectal cancer: Implications for diagnosis and therapy (Review)
Nguyen, H., & Duong, H. (2018) · Oncology Letters · doi:10.3892/ol.2018.8679 · Cited by 244
Gatalica, Z., Vranic, S., Xiu, J., Swensen, J., & Reddy, S. (2016) · Familial Cancer · doi:10.1007/s10689-016-9884-6 · Cited by 141
Guo, Y., Ayers, J. L., Carter, K. T., Wang, T., Maden, S. K., Edmond, D., Newcomb P, P., Li, C., Ulrich, C., Yu, M., et al. (2019) · Aging Cell · doi:10.1111/acel.13013 · Cited by 139
Metadata
- Authors
- Coppedè, F.
- Venue
- World Journal of Gastroenterology
- Publisher
- Baishideng Publishing Group Inc.
- Published
- 2014
- Volume
- 20
- Issue
- 4
- Pages
- 943
- ISSN
- 1007-9327 (ISSN-L)
- OpenAlex
- W1968907488
- Cited by
- 264
- References
- 115
- FWCI
- 15.70
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.